Skip to main content

Find Clinical Trials

Home
Conditions
Skin Diseases, Vesiculobullous

Clinical trial condition

Skin Diseases, Vesiculobullous

Explore clinical trials studying Skin Diseases, Vesiculobullous. Study availability and eligibility vary by location and protocol.

235 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Vesiculobullous trial results

Completed

Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration

NCT02493283

Conditions: Autoimmune Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University Greifswald Greifswald, Mecklenburg-Vorpommern, Germany

View Trial Details

Completed

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

NCT00135720

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Clinical Unit for Research Trials in Skin Boston, Massachusetts, United States

View Trial Details

Completed

Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa

NCT00014729

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, +10 more
Locations: Not specified

View Trial Details

Completed

Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara

NCT01556308

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +10 more
Locations: Hôpital Archet 2 Nice, France

View Trial Details

Completed

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

NCT01696500

Conditions: Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +15 more
Locations: Nihon Pharmaceutical Co., Ltd Tokyo, Japan

View Trial Details

Completed

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

NCT00904163

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)

NCT00951964

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations: Dermatology Department, Bordeaux University Hospital Bordeaux, France

Dijon University Hospital, Dermatology Department Dijon, France

Dermatology Department, Necker Enfants Malades, APHP Paris, France

Dermatology Department, Saint Louis Hospital, APHP Paris, France

View Trial Details

Completed

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

NCT01408550

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: Osaka, Japan

View Trial Details

Completed

Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus

NCT00213421

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: UH-rouen Rouen, Seine maritime, France

View Trial Details

Completed

Effect of Anti CD20 in Pemphigus Desease

NCT00213512

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: UH-Rouen Rouen, Seine maritime, France

View Trial Details